Hypomagnesemia as a risk factor for the non-recovery of the renal function in critically ill patients with acute kidney injury

Nephrology Dialysis Transplantation

Volumn 28, Issue 4, 2013, Pages 910-916

  Alves, Sarah Cascaes ^a   Tomasi, Cristiane Damiani ^a   Constantino, Larissa ^a   Giombelli, Vinícius ^a   Candal, Roberta ^a   De Lourdes Bristot, Maria ^a   Topanotti, Maria Fernanda ^a   Burdmann, Emmanuel A ^b   Dal Pizzol, Felipe ^a,c   Fraga, Cassiana Mazon ^a,c   Ritter, Cristiane ^a,c  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL SÃO JOSÉ   (Brazil)

Author keywords

acute kidney injury; hypomagnesemia; ICU; magnesium; recovery; RIFLE

Indexed keywords

CREATININE; HYPERTENSIVE FACTOR; MAGNESIUM;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITERION VARIABLE; CRITICALLY ILL PATIENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOMAGNESEMIA; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LENGTH OF STAY; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; URINE VOLUME;

ACUTE KIDNEY INJURY; CRITICAL ILLNESS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; KIDNEY; KIDNEY FUNCTION TESTS; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84875977600     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs268     Document Type: Article

References (22)

1. Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med 2005; 20: 3-17 (Pubitemid 43093904)
2. Campos SB, Silva JC, Seguro AC. Hypomagnesemia potentiates postischemic acute renal failure. J Am Soc Nephrol 2001; 12: A4057
3. de Araujo M, Andrade L, Coimbra TM et al. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure. J Am Soc Nephrol 2005; 16: 3339-3349 (Pubitemid 46179337)
4. Santos MS, Seguro AC, Andrade L. Hypomagnesemia is a risk factor for nonrecovery of renal function and mortality in AIDS patients with acute kidney injury. Braz J Med Biol Res 2010; 43: 316-323
5. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256 (Pubitemid 36444440)
6. Chernow B, Bamberger S, Stoiko M et al. Hypomagnesemia in patients in postoperative intensive care. Chest 1989; 95: 391-397 (Pubitemid 19051424)
7. Bellomo R, Ronco C, Kellum JA et al.; Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212
8. Santos WJ, Zanetta DM, Pires AC et al. Patients with ischaemic, mixed and nephrotoxic acute tubular necrosis in the intensive care unit-a homogeneous population? Crit Care 2006; 10: R68
9. Shechter M, Sharir M, Labrador MJ et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000; 102: 2353-2358
10. Fandrey J, Rob PM, Jelkmann W. Theophylline and magnesium inhibit the contraction elicited with ciclosporin and angiotensin II in mesangial cell cultures. Nephron 1991; 57: 94-98
11. Asai T, Nakatani T, Tamada S et al. Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: Role in beneficial effects of magnesium supplementation. Transplantation 2003; 75: 1040-1044 (Pubitemid 36438535)
12. Seguro AC, Araujo M, Seguro FS et al. Effects of hypokalemia and hypomagnesemia on zidovudine (AZT) and didanosine (DDI) nephrotoxicity in rats. Clin Nephrol 2003; 59: 267-272 (Pubitemid 36511296)
13. Agus ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10: 1616-1622 (Pubitemid 29297539)
14. Murthi SB, Wise RM, Weglicki WB et al. Mg-gluconate provides superior protection against postischemic dysfunction and oxidative injury compared to Mg-sulfate. Mol Cell Biochem 2003; 245: 141-148 (Pubitemid 36416830)
15. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998; 136: 480-490 (Pubitemid 28413547)
16. Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980; 208: 198-200 (Pubitemid 10072143)
17. Holzmacher R, Kendziorski C, Michael Hofman R et al. Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity. Nephrol Dial Transplant. 2005; 20: 1456-1462 (Pubitemid 41430621)
18. Ishimura E, Okuno S, Yamakawa T et al. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 2007; 20: 237-244
19. Huijgen HJ, Soesan M, Sanders R et al. Magnesium levels in critically ill patients: What should we measure? Am J Clin Pathol 2000; 114: 688-695 (Pubitemid 33051903)
20. Rubeiz GJ, Thill-Baharozian M, Hardie D et al. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med 1993; 21: 203-209 (Pubitemid 23062833)
21. Safavi M, Honarmand A. Admission hypomagnesemia-impact on mortality on morbidity in critical ill patients. Middle East J Anesthesiol 2007; 19: 645-660
22. Guerin C, Cousin C, Mignot F et al. Serum and erythrocyte magnesium in critically ill patients. Intensive Care Med 1996; 22: 724-727 (Pubitemid 26355537)